UBS Group
ARRY

UBS Group’s Array Biopharma Inc ARRY Stock Holding History

UBS Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,301,849
Closed -$60.3M – 8571
2019
Q2 		$60.3M Buy
1,301,849
+1,159,448
+814% +$32.6M 0.02% 587
2019
Q1 		$3.47M Sell
142,401
-34,909
-20% -$727K ﹤0.01% 2504
2018
Q4 		$2.53M Buy
177,310
+30,064
+20% +$456K ﹤0.01% 2808
2018
Q3 		$2.24M Buy
147,246
+45,388
+45% +$696K ﹤0.01% 3124
2018
Q2 		$1.71M Sell
101,858
-211,687
-68% -$3.37M ﹤0.01% 3308
2018
Q1 		$5.12M Buy
313,545
+217,672
+227% +$3.49M ﹤0.01% 2288
2017
Q4 		$1.23M Buy
95,873
+2,312
+2% +$26.3K ﹤0.01% 3602
2017
Q3 		$1.15M Sell
93,561
-21,844
-19% -$203K ﹤0.01% 3599
2017
Q2 		$966K Buy
115,405
+78,090
+209% +$639K ﹤0.01% 3645
2017
Q1 		$334K Sell
37,315
-130,204
-78% -$1.39M ﹤0.01% 4312
2016
Q4 		$1.47M Buy
167,519
+138,635
+480% +$1.02M ﹤0.01% 3199
2016
Q3 		$195K Sell
28,884
-52,191
-64% -$202K ﹤0.01% 4566
2016
Q2 		$289K Buy
81,075
+20,029
+33% +$65.3K ﹤0.01% 4288
2016
Q1 		$180K Sell
61,046
-241,469
-80% -$723K ﹤0.01% 4565
2015
Q4 		$1.28M Buy
302,515
+230,588
+321% +$1.05M ﹤0.01% 3207
2015
Q3 		$328K Buy
71,927
+10,556
+17% +$62.6K ﹤0.01% 4237
2015
Q2 		$443K Buy
61,371
+1,747
+3% +$12.9K ﹤0.01% 4230
2015
Q1 		$439K Buy
59,624
+629
+1% +$4.48K ﹤0.01% 4245
2014
Q4 		$279K Buy
+58,995
New +$233K ﹤0.01% 4717

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group's ARRY Position: Q3 2019 in Review

UBS Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,301,849 shares — an estimated $60.3M sold.

UBS Group first reported a position in ARRY in Q4 2014 and held it in 19 quarters. The position peaked at $60.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • UBS Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • UBS Group sold 1,301,849 Array Biopharma Inc shares in Q3 2019, an estimated $60.3M.
  • UBS Group first reported a position in Array Biopharma Inc in Q4 2014 and held it in 19 quarters.
  • UBS Group's Array Biopharma Inc position peaked at $60.3M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.